Association of polygenic risk scores with Alzheimer's disease and plasma biomarkers among Chinese older adults: A community-based study

Alzheimers Dement. 2024 Oct;20(10):6669-6681. doi: 10.1002/alz.13924. Epub 2024 Aug 22.

Abstract

Introduction: We examined the associations of polygenic risk score (PRS) with Alzheimer's disease (AD) and plasma biomarkers in the Chinese population.

Methods: This population-based study used baseline data from MIND-China (2018; n = 4873) and follow-up data from dementia-free individuals (2014-2018; n = 2117). We measured AD-related plasma biomarkers in a subsample (n = 1256). Data were analyzed using logistic and Cox regression models.

Results: We developed PRS with (PRSAPOE) and without (PRSnon- APOE) apolipoprotein E (APOE) gene. In the longitudinal analysis, PRSAPOE was associated with a multivariable-adjusted hazards ratio of 1.91 (95% CI = 1.13-3.23) for AD. PRSAPOE in combination with demographics yielded discriminative (area under the curve [AUC]) and predictive(C-statistic) accuracy of 0.80 (95% confidence interval [CI] = 0.77-0.84) and 0.80 (0.77-0.82), respectively. PRSnon- APOE showed an association with AD risk similar to PRSAPOE. PRSAPOE, but not PRSnon- APOE, was associated with reduced plasma Aβ42/Aβ40 ratio and increased Neurofilament light chain (NfL) (p < 0.05).

Discussion: The PRS with and without APOE gene, in combination with demographics, shows good discriminative and predictive ability for AD. The AD-related pathologies underlie AD risk associated with PRSAPOE.

Highlights: The PRSAPOE and PRSnon- APOE were associated with AD risk in the Chinese population. The PRSAPOE and PRSnon- APOE, in combination with demographics, showed good discriminative and predictive ability for AD. The AD-related pathologies underlie the AD risk associated with PRSAPOE but not PRSnon- APOE.

Keywords: Alzheimer's disease; plasma Alzheimer's biomarkers; polygenic risk score; population‐based study.

MeSH terms

  • Aged
  • Alzheimer Disease* / blood
  • Alzheimer Disease* / genetics
  • Amyloid beta-Peptides* / blood
  • Apolipoproteins E* / blood
  • Apolipoproteins E* / genetics
  • Biomarkers / blood
  • China
  • East Asian People / genetics
  • Female
  • Genetic Predisposition to Disease
  • Genetic Risk Score*
  • Humans
  • Longitudinal Studies
  • Male
  • Neurofilament Proteins / blood
  • Neurofilament Proteins / genetics

Substances

  • Amyloid beta-Peptides
  • Apolipoproteins E
  • Biomarkers
  • Neurofilament Proteins

Grants and funding